Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of September 15, 2026, GKOS trades at $170.21 with a market cap of $9.87B and a P/E ratio of -52.13. GKOS moved -0.43% today. Year to date, GKOS is +51.53%; over the trailing twelve months it is +106.73%. Its 52-week range spans $73.16 to $191.62. Analyst consensus is strong buy with an average price target of $193.58. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Glaukos Corporation (GKOS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GKOS moved -0.43% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $170.21 |
| Market Cap | $9.87B |
| P/E Ratio | -52.13 |
| EPS | $-3.26 |
| Dividend Yield | 0.00% |
| 52-Week High | $191.62 |
| 52-Week Low | $73.16 |
| Volume | 58.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $612.84M |
| Net Income | $-188.05M |
| Gross Margin | 60.70% |
13 analysts cover GKOS: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $193.58.